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Abstract
Objectives: The intermittent Pringle maneuver (IPM) is frequently applied to minimize blood loss during liver transection.
Clamping the hepatoduodenal ligament blocks the hepatic inflow, which leads to a non circulating (hepato)splanchnic
outflow. Also, IPM blocks the mesenteric venous drainage (as well as the splenic drainage) with raising pressure in the
microvascular network of the intestinal structures. It is unknown whether the IPM is harmful to the gut. The aim was to
investigate intestinal epithelial cell damage reflected by circulating intestinal fatty acid binding protein levels (I-FABP) in
patients undergoing liver resection with IPM.
Methods: Patients who underwent liver surgery received total IPM (total-IPM) or selective IPM (sel-IPM). A selective IPM was
performed by selectively clamping the right portal pedicle. Patients without IPM served as controls (no-IPM). Arterial blood
samples were taken immediately after incision, ischemia and reperfusion of the liver, transection, 8 hours after start of
surgery and on the first post-operative day.
Results: 24 patients (13 males) were included. 7 patients received cycles of 15 minutes and 5 patients received cycles of
30 minutes of hepatic inflow occlusion. 6 patients received cycles of 15 minutes selective hepatic occlusion and 6 patients
underwent surgery without inflow occlusion. Application of total-IPM resulted in a significant increase in I-FABP 8 hours
after start of surgery compared to baseline (p,0.005). In the no-IPM group and sel-IPM group no significant increase in I-
FABP at any time point compared to baseline was observed.
Conclusion: Total-IPM in patients undergoing liver resection is associated with a substantial increase in arterial I-FABP,
pointing to intestinal epithelial injury during liver surgery.
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Introduction
Intra-operative blood loss and red blood cell transfusions are
associated with short- and long-term complications in liver surgery,
such as operative mortality or major complications that require
post-operative radiologic or surgical intervention [1,2]. Intra-
operative blood loss also predisposes patients to post-resectional
liver failure [2]. In an attempt to avoid blood loss, the intermittent
Pringle maneuver (IPM) is frequently applied in patients undergoing
liver surgery. This implies intermittent clamping of the hepatoduo-
denal ligament, thereby occluding hepatic inflow [3].
IPM may have a negative effect on outcome after liver resection
as a consequence of liver injury due to ischemia reperfusion (I/R)
damage [4]. On the other hand, a short period of clamping of the
portal triad is also used as a pre-conditioning method in order to
protect the liver against ischemia damage when continuous
clamping is performed [5,6]. I/R damage of the liver as a
consequence of IPM has been well studied, however little is known
about the effects of IPM on the gut. Clamping the hepatoduodenal
ligament causes stasis in the portal vein and the superior and
inferior mesenteric veins, thereby reducing splanchnic outflow [7].
Intestinal hypoperfusion leads to enterocyte damage and gut
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barrier loss [8]. The effect of splanchnic hypoperfusion on
intestinal damage as a consequence of IPM has been proven in
several animal studies [9–11]. Sheen-Chen et al. [12] showed
recently in rats that occlusion of the hepatoduodenal ligament
significantly increased jejunal apoptosis. However, data on the
effect of IPM on the gut in man are scarce. Loss of intestinal
epithelial integrity is clinically important, as it is associated with
the development of sepsis and multiple organ failure (MOF)
following major surgery, trauma and shock [13,14]. This might be
especially important in patients with small for size liver remnant
volume and/or parenchymal dysfunction due to neo-adjuvant
chemotherapy, cholestasis and/or cirrhosis [15–17].
Intestinal fatty acid binding protein (I-FABP) is a small, water-
soluble cytosolic protein that is easily released into the circulation
upon enterocyte membrane integrity loss. I-FABP is solely present
in mature epithelial cells of the small intestine and to a lesser
extent in the large intestine [18]. We [8,19] and others [18,20,21]
have shown that I-FABP is an accurate marker for intestinal
epithelial cell damage.
The principal aim of this study was to investigate whether IPM
causes intestinal epithelial cell damage and barrier loss in patients
undergoing liver resection.
Methods
Patients
Patients who underwent liver surgery at Maastricht University
Medical Center were eligible for inclusion in this prospective trial.
The study was approved by the medical ethical committee of
Maastricht University Medical Center and conducted according to
the revised version of the Declaration of Helsinki (October 2008,
Seoul). All patients gave written informed consent.
Pre-operatively it was decided whether a Pringle maneuver was
required according to the surgeon’s preference. If a Pringle
maneuver was required, patients were randomly assigned to IPM
with 15 (15-IPM) or 30 minutes (30-IPM) ischemic intervals.
Patients who did not require IPM served as controls (no-IPM).
These patients were investigated in an RCT on a different topic by
our group in the recent past [22]. The current study uses samples
obtained from this previous RCT titled ‘Randomized controlled
trial analyzing the effect of 15 or 30 min intermittent Pringle
maneuver on hepatocellular damage during liver surgery’. The
trial is registered at ClinicalTrials.gov - registration number:
NCT01099475. No new randomization was carried out for this
study. A subgroup of 6 selective intermittent Pringle maneuver
patients (15 minutes ischemic intervals, sel-IPM) was added to the
present study. The addition of these patients was approved by the
above-mentioned IRB, and informed consent was obtained from
each. The 15-IPM and 30-IPM groups were later pooled in a
subanalysis to compare total-IPM and no-IPM.
Operative procedure
Pre-operatively, all patients had radial artery and central venous
catheters inserted to monitor arterial and central venous pressure
as part of standard anesthetic care. Liver resection was performed
as detailed elsewhere [23]. Resections were classified as major ($3
segments) or minor (,3 segments or non-anatomical) resections.
Laparotomy was performed by bilateral subcostal incision, fol-
lowed by intraoperative ultrasonographic assessment of the liver.
Once resectability had been confirmed, mobilization of the liver
was performed to prepare for hepatic parenchymal transection,
which was undertaken using a Cavitron Ultrasonic Surgical
Aspirator (Force GSU System; Valleylab, Boulder, CO). Argon
beam coagulation (Erbe, Germany, Tu¨bingen), clips and sutures
were used for hemostasis. Central venous pressure was maintained
below 5 cm H2O during transection to reduce venous back-
bleeding. The Pringle maneuver was performed by tightening a
rubber tube around the entire hepatoduodenal ligament (total
Pringle maneuver) or selectively around the left or right portal
pedicle using an extra Glissonian approach [24]. Cycles of 15 or
30 minutes of occlusion were alternated with 5 minutes of
reperfusion. The control and Pringle manoeuvre patients were
operated by the same surgeons.
Blood sampling and processing
Arterial blood samples were obtained from the radial artery line
at predefined time points (figure 1). Blood samples were collected
in pre-chilled EDTA containing vacuum tubes (BD vacutainer,
Becton Dickinson Diagnostics, Aalst, Belgium) and kept on ice.
Blood was centrifuged in a pre-chilled centrifuge at 4uC (3500
rotations per minute, 15 minutes). Plasma was immediately stored
at 280uC until batch analysis. All analyses were performed by one
person after completion of patient inclusion. Patients were
admitted to the hospital one day pre-operatively and routine
blood tests were performed by the clinical chemistry department.
I-FABP measurement
I-FABP is a highly sensitive and specific marker of intestinal
epithelial cell damage [19]. I-FABP plasma levels were determined
using an in-house enzyme-linked immunosorbent assay (ELISA)
that selectively detects human I-FABP (range: 10–1280 pg/ml).
Due to its small molecular weight, plasma I-FABP passes the
glomerular filter (fractional renal excretion: 28%, half-life time:
11 minutes) [25].
Source and fate of I-FABP
In order to measure the source and fate of I-FABP, blood was
also drawn from the portal vein and hepatic vein after liver
transection in the no-IPM and total-IPM group (T= 4, figure 1).
Arterio-venous (AV) differences of I-FABP across the gut and the
hepatosplanchnic area (gut+liver) were calculated. AV-differences
of I-FABP were calculated using the following formulae:
AV-difference gut = portal venous [I-FABP]2arterial [I-FABP]
Hepatosplanchnic AV-difference = hepatovenous [I-FABP]2
arterial [I-FABP].
EndoCAb measurement
IgG Endotoxin Core Antibodies were used to quantify
endotoxemia. A drop from pre-operative values to post-operative
values was interpreted as consumption of antibodies to endotoxin
by systemic release of endotoxin. IgG EndoCAb was measured
using a commercially available enzyme-linked immunosorbent
Figure 1. Timeline of sample collection.
doi:10.1371/journal.pone.0030539.g001
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assay (ELISA), kindly provided by Hycult Biotechnology, Uden,
the Netherlands (range: 0.13–8.00 GMU/ml). EndoCAb data are
expressed in General Median Units (GMU)/ml. General Median
Units of IgG are arbitrary and are based on medians of healthy
adults, with 100 GMU/ml being the median.
Statistics
Mann Whitney U test was applied for two group comparison for
continuous data. Wilcoxon signed rank test was applied for
pairwise comparison for continuous data. Dichotomous data were
compared using Fisher exact test. Multiple group comparisons for
continuous data were done by Kruskal-Wallis test, with Dunn’s
post hoc test. All data are expressed as median and range. A p-
value,0.05 was considered statistically significant. Statistical
analysis was performed using Prism 5.0 for Windows (Graphpad
software, Inc, San Diego, CA).
Results
Patients
Twenty-four patients (11 females; 13 males) scheduled for
hepatectomy for primary (n = 2) or secondary malignant liver
tumours (n = 22) were included. Thirteen patients underwent
major liver resections ($3 segments) and eleven a minor liver
resection (,3 segments). The 15-IPM group received 15 minutes
of ischemia (n = 7), median 2 (2–5) cycles and a cumulative total
ischemia time of 33 (30–75) minutes. The 30-IPM group received
30 minutes of ischemia (n = 5), median 1 (1–2) cycle and a
cumulative total ischemia time of 30 (30–56) minutes.
The sel-IPM group received selective clamping of the right
portal pedicle (n = 6), and controls (no-IPM) received no vascular
clamping (n= 6). There were no relevant significant differences
between groups neither in baseline characteristics (table 1) nor in
operation time, intra-operative blood loss, extent of resection and
post-operative creatinin levels (table 2). There were no significant
differences in pre- and post-operative creatinin levels (table 1,2).
Plasma baseline I-FABP values
Baseline (T= 1) arterial I-FABP levels did not differ significantly
between groups (15-IPM, 532 pg/ml [353–1,078]; 30-IPM,
565 pg/ml [500–1,156]; sel-IPM, 874 pg/ml [478–1,198]; no-
IPM, 502 pg/ml [161–966] p = 0.26).
Intestinal epithelial injury in 15 min vs. 30 min total IPM
No significant differences between 15-IPM and 30-IPM groups
in median plasma I-FABP values were found at any time point. In
the 15 minutes IPM group a significant increase in I-FABP was
observed from baseline (T= 1) to after transection (T= 4) (15-IPM:
532 pg/ml [353–1,078] to 891 pg/ml [392–3,053] p,0.05) and
from baseline (T=1) to 8 hours after start of surgery (T= 5) (15-
IPM: 532 pg/ml [353–1,078] to 1,478 pg/ml [627–2,000]
p,0.05). Application of 30 minutes cycles of inflow occlusion
did not significantly increase the release of I-FABP (30-IPM:
597 pg/ml [500–1,156] to 1,077 pg/ml [560–1,664], p=0.19).
Intestinal epithelial injury in total IPM vs. control
The 15-IPM and 30-IPM groups were subsequently pooled and
compared with controls (no-IPM) since there was no significant
difference in intestinal epithelial cell damage between 15-IPM and
30-IPM. In the total-IPM group, plasma I-FABP levels increased
significantly from baseline to 8 hours after start of surgery
(549 pg/ml [353–1,156] to 1,279 pg/ml [560–2,000], p,0.005).
In the no-IPM group, no significant differences were observed in I-
FABP concentrations between the different time points. Conse-
quently, plasma I-FABP levels 8 hours after start of surgery were
significantly higher in the total-IPM group compared to the no-
IPM group (respectively, 1,279 pg/ml [560–2,000] and 413 pg/
ml [245–1,388], p,0.01) (figure 2A).
Intestinal epithelial injury in sel-IPM
In patients who received selective clamping of the right portal
pedicle (sel-IPM), plasma I-FABP levels did not increase
significantly from baseline to 8 hours after start of surgery
(806 pg/ml [478–1,198] to 924 pg/ml [248–2,823], p=0.31).
Moreover, there were no significant differences at any time point
between sel-IPM and no-IPM.
Organ specific I-FABP release
In order to prove that I-FABP is specifically released from the
gut we performed an organ balance analysis to reveal the origin of
Table 1. Patient characteristics.
15 min total-IPM
(n=7)
30 min total-IPM
(n=5)
No-IPM
(n=6)
Sel-IPM
(n=6) p
Age (years) 60.8 (48.3–79.9) 67.3 (60.3–77.4) 60.5 (59.6–70.1) 64.6 (42.9–70.1) 0.64
Gender (3 F; 4 M) (2 F; 3 M) (1 F; 5 M) (5 F; 1 M) 0.14
Height (cm) 1.77 (1.55–1.92) 1.70 (1.63–1.75) 1.76 (1.72–1.95) 1.65 (1.60–1.86) 0.11
Weight (kg) 72 (56–100) 74 (54–83) 75 (68–90) 71 (55–88) 0.83
Body Mass Index 23.2 (22.6–27.4) 24.2 (20.3–28.7) 23.4 (23.0–25.7) 25.1 (19.3–30.8) 0.70
Aspartate-aminotransferase (IU/L) 33 (13–52) 16 (7–25) 21 (10–32) 19 (11–26) 0.13
Alanine-aminotransferase (IU/L) 36 (11–51) 26 (8–41) 26 (7–55) 23 (21–29) 0.75
Lactate dehydrogenase (IU/L) 399 (305–595) 356 (299–432) 319 (291–557) 389 (316–514) 0.55
Gamma-glutamyl transpeptidase (IU/L) 56 (22–204) 37 (32–169) 34 (18–83) 33 (29–63) 0.61
Alkaline phosphatase (IU/L) 134 (55–256) 90 (66–124) 80 (58–128) 115 (57–126) 0.52
Bilirubin (mM) 13.8 (11.3–14.2) 10.6 (8.3–13.0) 14.0 (6.9–16.5) 11.3 (7.8–12.9) 0.15
Pre-operative creatinin (mmol/L) 78 (59–125) 92 (85–137) 76 (54–96) 80.5 (46–287) 0.40
Data are presented as median (range). All data are preoperative values.
doi:10.1371/journal.pone.0030539.t001
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circulating I-FABP. The data show that I-FABP was specifically
released from the gut after liver transection. This resulted in a net
release of I-FABP from the hepatosplanchnic area (figure 2B).
Determination of endotoxemia
Plasma levels of natural IgG against endotoxin were signifi-
cantly decreased in the total-IPM group on post-operative day 1
(POD1) compared to baseline (baseline, 52.9 GMU/mL [10.0–
112.1], POD1, 33.2 GMU/mL [10.0–89.1] p,0.005). In the no-
IPM and sel-IPM group, no significant decrease from baseline to
POD1 was observed (figure 3).
Discussion
This study aimed to investigate whether IPM causes loss of
intestinal epithelial cell integrity and leads to endotoxemia in
patients undergoing liver resection. The results of the present study
show that the use of total IPM is associated with intestinal
epithelial cell damage and subsequent endotoxemia. In the total-
IPM group (15 min and 30 min total IPM combined), plasma I-
FABP levels were significantly increased 8 hours after start of
surgery compared to baseline, while in the no-IPM group and sel-
IPM group no significant differences in I-FABP levels were
observed between different time points. By measuring concentra-
tion differences across the gut and the hepatosplanchnic area, we
were able to show that there was a net I-FABP release from the
hepatosplanchnic area in the total-IPM group, explaining the high
levels of I-FABP in this group.
In the total-IPM group IgG EndoCAb decreased significantly
on POD1 compared to baseline while this effect was not observed
in the no-IPM and sel-IPM group. Consumption of IgG EndoCAb
in the total IPM group suggests that total IPM resulted in
translocation of gut derived endotoxins, possibly by intestinal
barrier dysfunction due to epithelial cell damage.
The results of the present study are in line with several animal
studies. Ochiai et al. [9] showed that IPM caused intestinal epithelial
cell damage and increased small intestinal permeability in rats. In
two other rat studies, increased bacterial translocation [10] and
endotoxemia [10,11] were demonstrated after IPM. Data on the
effect of IPM on the gut in man are scarce. It remains unknown
whether it is only the impaired microcirculation in the intestine
during portal clamping which causes cell damage or that the
temporal acute rise of venous pressure in the mesenteric system in
itself also plays a role. King et al. [26] showed that when splanchnic
venous outflow was occluded in patients, both intestinal oxygen
extraction ratio and portal venous lactate increased. An acute rise of
venous pressure in the microcirculation in itself will probably also
impair perfusion and consequently cause tissue hypoxia. It is most
likely a combination of the two mechanisms that explains the high
levels of I-FABP in these patients. It would be worthwhile to study
the microcirculation in vivo during the total IPM in order to further
explore the pathophysiological mechanism behind the intestinal cell
damage in these patients. In this context Ferri et al. [27] showed that
bacterial translocation to mesenteric lymph nodes occurred during
liver resection in patients under continuous inflow occlusion, but
there was no correlation between positive lymph nodes and post-
operative infectious complications.
Table 2. Characteristics of surgical procedures.
15 min total-IPM
(n=7)
30 min total-IPM
(n=5)
No-IPM
(n=6)
Sel-IPM
(n=6) p
Operation time
(hours: minutes)
3:15 h (2:10–6:30) 4:15 h (3:09–4:45) 3:24 h (2:20–4:10) 3:45 h (2:27–4:30) 0.62
Blood loss (ml) 850 (250–3900) 1000 (250–2500) 750 (200–2600) 1050 (400–2500) 0.93
Number of resected segments 3 (2–3) 3(1–3) 2 (1–3) 3 (2–3) 0.48
Post-operative creatinin (mmol/L) day 0/1 71 (55–114) 110 (101–115) 88 (52–93) 76 (44–248) 0.17
Data are presented as median (range).
doi:10.1371/journal.pone.0030539.t002
Figure 2. Time course of I-FABP plasma levels and interorgan
arterio-venous concentration differences. 2A For visual purposes
data were plotted as mean and SEM. * p,0.005 compared to baseline
of total-IPM (T = 0), p,0.01 compared to no-IPM on T=5. 2B Mean
(SEM) arterio-venous concentration gradients of I-FABP across the gut
(portal venous minus arterial) and the hepatosplanchnic area (hepatic
venous minus arterial). I-FABP was specifically released from the gut
(*p,0.0001 vs. zero) and this resulted in a net I-FABP release from the
hepatosplanchnic area (# p,0.005 vs. zero).
doi:10.1371/journal.pone.0030539.g002
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Patients undergoing liver resection are more susceptible to
development of a systemic inflammatory response due to endo-
toxemia, as hepatic endotoxin clearance is compromised due to a
reduction of Kuppfer cells [28]. This is caused by reduction of the
functional hepatic liver mass and by ischemia reperfusion damage
to the functional liver parenchyma when IPM is applied.
Translocation of intraluminal intestinal toxins as a consequence
of intestinal epithelial cell damage due to total-IPM could further
contribute to systemic endotoxemia. It may therefore play an
important role in the pathogenesis of the systemic inflammatory
response syndrome (SIRS) and sepsis in patients undergoing liver
resection. In line with this, infective complications are reported to
negatively affect both short- and long-term outcome after liver
resection [29,30]. This might be especially important in patients
with underlying liver disease and cholestasis. In the latter, most
often infected areas of non-optimally drained liver segments are
present during surgery [31]. To prove these assumptions it would
be worthwhile to investigate in future studies whether there is a
relation between infective complications and the application of the
total-IPM.
The present study sheds new light on the question whether
performing IPM is favorable in patients undergoing liver surgery.
Hepatectomies without IPM can be performed safely due to
advances in liver surgery such as the development of modern
hemostatic devices and improvements in anesthesiological man-
agement [32]. Acute major bleeding remains an indication for
IPM, but current evidence shows no benefit for IPM on outcome
after liver resection [33]. Therefore in the modern era of liver
surgery systematic use of IPM has become more often a subject of
debate. Our data show that total-IPM is associated with intestinal
epithelial cell damage and endotoxemia. This could play a role in
the pathophysiology of infective postoperative complications. It is
clinically relevant that the role of gut integrity loss induced by
ischemia/reperfusion of the liver during liver resections and liver
transplantations is further investigated in future studies. This
pathophysiologic mechanism is probably underestimated in these
patients. Unravelling this mechanism could help to (preoperative-
ly) identify patients with a higher risk of infective postoperative
complications.
A possibly more safe approach than total IPM is selective IPM,
which is performed by selectively excluding the right or left hemi
liver from the circulation. Selectively clamping the right or left
portal pedicle is safe and feasible for patients with normal liver
parenchyma and especially in cirrhotic patients the selective IPM
induces less ischemic liver injury compared to total IPM [34]. One
would expect that also the intestinal epithelial cell integrity is less
compromised in these patients because splanchnic outflow is only
partly reduced. This hypothesis was confirmed in the present study
as no significant increase was observed in arterial I-FABP levels in
6 patients undergoing selective IPM. However, there were no
significant differences on any time point between the sel-IPM
group and the total-IPM group. This is probably due to the
relatively small group size (type II error), as only one patient
showed a substantial increase in I-FABP.
The present study shows that the use of the total intermittent
Pringle maneuver causes intestinal epithelial cell damage and
endotoxemia during liver surgery in man. IPM can therefore
potentially increase the risks of liver resections despite a possible
reduction of intraoperative blood loss. Intestinal epithelial cell
damage and endotoxemia induced by IPM could negatively affect
the patient’s condition and post-operative recovery. Whether gut
damage as a consequence of the total-IPM is causally related to
systemic inflammation remains to be established.
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